CLEVIDIPINE

CLEVIDIPINE was reported 367 times

CLEVIDIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SHUNT BLOOD FLOW EXCESSIVE 2 0.1250
1 CARDIAC SEPTAL DEFECT RESIDUAL SHUNT 1 0.1000
2 VENTILATION PERFUSION MISMATCH 25 0.0890
3 URINARY LIPIDS PRESENT 1 0.0833
4 PREMATURE RECOVERY FROM ANAESTHESIA 2 0.0556
5 VOCAL FOLD IMMOBILITY 1 0.0526
6 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 1 0.0161
7 VENOUS OXYGEN SATURATION DECREASED 1 0.0141
8 OCULAR ISCHAEMIC SYNDROME 1 0.0118
9 RESPIRATORY GAS EXCHANGE DISORDER 4 0.0108
10 POSTOPERATIVE DELIRIUM 2 0.0101
11 WITHDRAWAL HYPERTENSION 2 0.0099
12 OBSTRUCTIVE SHOCK 1 0.0092
13 INTERSTITIAL LUNG ABNORMALITY 1 0.0088
14 PRODUCT DOSAGE FORM CONFUSION 1 0.0083
15 VASCULAR RESISTANCE SYSTEMIC DECREASED 1 0.0075
16 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
17 BASILAR ARTERY OCCLUSION 1 0.0060
18 TACHYPHYLAXIS 2 0.0057
19 BASILAR ARTERY THROMBOSIS 1 0.0056
20 CEREBRAL MASS EFFECT 2 0.0055
21 PROCEDURAL HYPERTENSION 1 0.0053
22 ABNORMAL CLOTTING FACTOR 1 0.0049
23 INFUSION SITE PHLEBITIS 1 0.0044
24 DRUG LABEL CONFUSION 1 0.0040
25 NEPHRITIC SYNDROME 1 0.0032
26 EXTRAVASATION 13 0.0032
27 PO2 DECREASED 3 0.0026
28 PENILE HAEMORRHAGE 2 0.0025
29 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
30 OPERATIVE HAEMORRHAGE 1 0.0022
31 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
32 INFUSION SITE VESICLES 1 0.0019
33 EPIGLOTTITIS 1 0.0018
34 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
35 BLOOD MAGNESIUM ABNORMAL 1 0.0018
36 HYPERTENSIVE URGENCY 1 0.0018
37 CATHETER SITE INFLAMMATION 1 0.0018
38 ARTERIAL HAEMORRHAGE 2 0.0017
39 GRAFT COMPLICATION 1 0.0017
40 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
41 INFUSION SITE EXTRAVASATION 10 0.0016
42 EYE ROLLING 1 0.0014
43 JARISCH-HERXHEIMER REACTION 1 0.0014
44 PULMONARY ARTERY THROMBOSIS 1 0.0013
45 LABORATORY TEST INTERFERENCE 1 0.0013
46 HYPERTRIGLYCERIDAEMIA 7 0.0012
47 BLOOD AMYLASE INCREASED 2 0.0012
48 NODAL ARRHYTHMIA 1 0.0012
49 VASOSPASM 1 0.0011
50 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
51 BRAIN STEM INFARCTION 1 0.0010
52 PERIODONTITIS 2 0.0009
53 KETOSIS 1 0.0009
54 PRODUCT NAME CONFUSION 1 0.0009
55 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
56 DEMENTIA WITH LEWY BODIES 1 0.0009
57 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
58 INCISION SITE PAIN 1 0.0009
59 FEBRILE INFECTION 1 0.0008
60 HYPERTENSIVE EMERGENCY 1 0.0008
61 INFUSION SITE WARMTH 1 0.0008
62 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
63 BLOOD BILIRUBIN ABNORMAL 1 0.0008
64 DRUG TITRATION ERROR 2 0.0008
65 PROTEIN TOTAL ABNORMAL 1 0.0008
66 HYPOXIA 27 0.0008
67 PRODUCT LABEL ISSUE 5 0.0007
68 ECHOCARDIOGRAM ABNORMAL 1 0.0007
69 INFUSION SITE INDURATION 1 0.0007
70 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
71 INFUSION SITE SWELLING 4 0.0006
72 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
73 VENOUS OCCLUSION 1 0.0005
74 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
75 HYPERTENSIVE CRISIS 6 0.0005
76 HAEMOLYSIS 4 0.0005
77 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
78 LIPIDS INCREASED 1 0.0005
79 VENOUS THROMBOSIS LIMB 1 0.0005
80 AORTIC DISSECTION 2 0.0005
81 ILEUS 6 0.0005
82 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
83 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
84 METHAEMOGLOBINAEMIA 1 0.0004
85 HYPOVOLAEMIC SHOCK 2 0.0004
86 PRODUCT PACKAGING CONFUSION 1 0.0004
87 VASODILATATION 1 0.0004
88 LIPASE INCREASED 3 0.0004
89 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
90 VENTRICULAR DYSFUNCTION 1 0.0004
91 LUNG OPACITY 1 0.0004
92 BLOOD POTASSIUM ABNORMAL 1 0.0004
93 BLOOD SODIUM INCREASED 1 0.0004
94 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
95 PRODUCT LABEL CONFUSION 2 0.0003
96 HYPERLIPIDAEMIA 4 0.0003
97 OXYGEN SATURATION DECREASED 18 0.0003
98 INFUSION SITE PRURITUS 1 0.0003
99 PULMONARY CONGESTION 4 0.0003
100 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
101 DRUG ADMINISTRATION ERROR 9 0.0003
102 THROMBOPHLEBITIS 1 0.0003
103 EMBOLIC STROKE 1 0.0003
104 CAROTID ARTERY OCCLUSION 1 0.0003
105 KETOACIDOSIS 2 0.0003
106 POST PROCEDURAL COMPLICATION 5 0.0003
107 CARDIOPULMONARY FAILURE 1 0.0003
108 AZOTAEMIA 1 0.0003
109 ORGAN FAILURE 1 0.0002
110 RHINITIS 2 0.0002
111 NO THERAPEUTIC RESPONSE 3 0.0002
112 BRADYCARDIA 13 0.0002
113 ACCIDENTAL EXPOSURE 1 0.0002
114 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
115 INFUSION SITE ERYTHEMA 2 0.0002
116 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
117 MENTAL STATUS CHANGES 6 0.0002
118 PULSE ABSENT 1 0.0002
119 STAPHYLOCOCCAL SEPSIS 1 0.0002
120 HYPERVOLAEMIA 1 0.0002
121 INFLAMMATORY MARKER INCREASED 1 0.0002
122 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
123 PRODUCT COMPLAINT 5 0.0002
124 SUBARACHNOID HAEMORRHAGE 2 0.0002
125 PRODUCT COLOUR ISSUE 1 0.0002
126 PETECHIAE 2 0.0002
127 TACHYCARDIA 17 0.0002
128 SERUM FERRITIN INCREASED 1 0.0002
129 ANGIOPATHY 1 0.0002
130 NEPHROPATHY TOXIC 2 0.0002
131 CHOLECYSTITIS ACUTE 1 0.0002
132 CORONARY ARTERY BYPASS 1 0.0002
133 HYPOVOLAEMIA 1 0.0002
134 CEREBRAL HAEMORRHAGE 6 0.0002
135 HEPATITIS B 1 0.0002
136 ENCEPHALOPATHY 4 0.0002
137 CARDIOMEGALY 2 0.0002
138 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
139 SWELLING OF EYELID 1 0.0002
140 POOR QUALITY DRUG ADMINISTERED 1 0.0002
141 ATRIAL FIBRILLATION 15 0.0002
142 HYPOTENSION 30 0.0001
143 GINGIVAL BLEEDING 2 0.0001
144 INFARCTION 1 0.0001
145 RESPIRATORY DISTRESS 4 0.0001
146 BLOOD TEST ABNORMAL 2 0.0001
147 SINUS TACHYCARDIA 2 0.0001
148 CARDIOGENIC SHOCK 2 0.0001
149 HAEMORRHAGE INTRACRANIAL 2 0.0001
150 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
151 TROPONIN INCREASED 1 0.0001
152 ACIDOSIS 1 0.0001
153 PROCEDURAL COMPLICATION 1 0.0001
154 PERICARDIAL EFFUSION 3 0.0001
155 FOOD ALLERGY 1 0.0001
156 APNOEA 1 0.0001
157 ACUTE MYELOID LEUKAEMIA 2 0.0001
158 PULMONARY HAEMORRHAGE 1 0.0001
159 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
160 MYASTHENIA GRAVIS 1 0.0001
161 ACUTE CORONARY SYNDROME 1 0.0001
162 EMBOLISM 1 0.0001
163 PSEUDOMONAS INFECTION 1 0.0001
164 UNRESPONSIVE TO STIMULI 3 0.0001
165 CARDIAC MURMUR 1 0.0001
166 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
167 NEUROTOXICITY 2 0.0001
168 GROIN PAIN 1 0.0001
169 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
170 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
171 PRESCRIBED OVERDOSE 2 0.0001
172 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
173 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
174 APHASIA 3 0.0001
175 DELIRIUM 3 0.0001
176 POST PROCEDURAL HAEMORRHAGE 1 0.0001
177 CAESAREAN SECTION 1 0.0001
178 VASCULITIS 1 0.0001
179 CEREBRAL INFARCTION 2 0.0001
180 CYTOPENIA 1 0.0001
181 HYPERCALCAEMIA 1 0.0001
182 GENERALISED OEDEMA 1 0.0001
183 INFUSION SITE PAIN 1 0.0001
184 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
185 BLOOD PRESSURE DECREASED 5 0.0001
186 PERIPHERAL COLDNESS 1 0.0001
187 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
188 FLUID OVERLOAD 1 0.0001
189 ANGIOEDEMA 3 0.0001
190 PULMONARY OEDEMA 3 0.0001
191 THERAPY NON-RESPONDER 3 0.0001
192 DRUG DISPENSING ERROR 1 0.0001
193 CYANOSIS 1 0.0001
194 ULCER 1 0.0001
195 VENTRICULAR TACHYCARDIA 1 0.0001
196 TREATMENT FAILURE 5 0.0001
197 COAGULOPATHY 1 0.0001
198 BLOOD UREA INCREASED 1 0.0001
199 CIRCULATORY COLLAPSE 1 0.0001
200 HEART RATE DECREASED 2 0.0001
201 PANCREATITIS 3 0.0001
202 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
203 LEUKOCYTOSIS 1 0.0001
204 RESPIRATORY FAILURE 4 0.0001
205 GASTRIC ULCER 1 0.0001
206 ACUTE RESPIRATORY FAILURE 1 0.0001
207 HEART RATE INCREASED 5 0.0001
208 CYTOKINE RELEASE SYNDROME 1 0.0000
209 CARDIAC FAILURE 4 0.0000
210 PRODUCT PHYSICAL ISSUE 1 0.0000
211 PRODUCT ADMINISTRATION ERROR 1 0.0000
212 PLEURAL EFFUSION 3 0.0000
213 RENAL FAILURE ACUTE 2 0.0000
214 LIVER FUNCTION TEST INCREASED 1 0.0000
215 ACUTE KIDNEY INJURY 7 0.0000
216 INFUSION RELATED REACTION 3 0.0000
217 FEBRILE NEUTROPENIA 3 0.0000
218 TRANSAMINASES INCREASED 1 0.0000
219 NO ADVERSE EVENT 8 0.0000
220 COGNITIVE DISORDER 2 0.0000
221 ARRHYTHMIA 2 0.0000
222 BLOOD PRESSURE FLUCTUATION 1 0.0000
223 PRESYNCOPE 1 0.0000
224 EPISTAXIS 3 0.0000
225 BLOOD PRESSURE INCREASED 6 0.0000
226 DRUG RESISTANCE 1 0.0000
227 HAEMATOMA 1 0.0000
228 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
229 HAEMOPTYSIS 1 0.0000
230 PANCYTOPENIA 2 0.0000
231 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
232 LIVER FUNCTION TEST ABNORMAL 1 0.0000
233 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
234 ACUTE MYOCARDIAL INFARCTION 1 0.0000
235 RESPIRATORY DISORDER 1 0.0000
236 EPILEPSY 1 0.0000
237 DYSPHAGIA 3 0.0000
238 LACTIC ACIDOSIS 1 0.0000
239 DEEP VEIN THROMBOSIS 2 0.0000
240 BLOOD CREATININE INCREASED 2 0.0000
241 URINARY RETENTION 1 0.0000
242 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
243 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
244 NEOPLASM PROGRESSION 1 0.0000
245 HYPERKALAEMIA 1 0.0000
246 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
247 UNDERDOSE 2 0.0000
248 RESTLESSNESS 1 0.0000
249 DRUG INEFFECTIVE 36 0.0000
250 DYSARTHRIA 1 0.0000
251 COLITIS 1 0.0000
252 SEIZURE 3 0.0000
253 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
254 DISORIENTATION 1 0.0000
255 CARDIAC ARREST 2 0.0000
256 RHABDOMYOLYSIS 1 0.0000
257 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
258 RENAL IMPAIRMENT 2 0.0000
259 HYPERTENSION 5 0.0000
260 SEPTIC SHOCK 1 0.0000
261 PRODUCT QUALITY ISSUE 3 0.0000
262 HYPOKALAEMIA 1 0.0000
263 RENAL DISORDER 1 0.0000
264 BLOOD CHOLESTEROL INCREASED 1 0.0000
265 PULMONARY EMBOLISM 2 0.0000
266 PYREXIA 7 0.0000
267 LEUKOPENIA 1 0.0000
268 SYNCOPE 2 0.0000
269 HAEMOGLOBIN DECREASED 2 0.0000
270 DRUG INTERACTION 3 0.0000
271 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
272 TREATMENT NONCOMPLIANCE 1 0.0000
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
274 ANAPHYLACTIC REACTION 1 0.0000
275 MEDICATION ERROR 1 0.0000
276 SEPSIS 2 0.0000
277 URTICARIA 3 0.0000
278 THROMBOCYTOPENIA 2 0.0000
279 CEREBROVASCULAR ACCIDENT 3 0.0000
280 CONVULSION 1 0.0000
281 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
282 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
283 ANAEMIA 3 0.0000
284 SWELLING FACE 1 0.0000
285 RENAL FAILURE 2 0.0000
286 NEUTROPENIA 2 0.0000
287 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
288 AGITATION 1 0.0000
289 OFF LABEL USE 11 0.0000
290 CARDIAC FAILURE CONGESTIVE 1 0.0000
291 THROMBOSIS 1 0.0000
292 MYOCARDIAL INFARCTION 2 0.0000
293 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
294 CARDIAC DISORDER 1 0.0000
295 BLOOD GLUCOSE INCREASED 2 0.0000
296 CONDITION AGGRAVATED 3 0.0000
297 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
298 ABDOMINAL DISTENSION 1 0.0000
299 HAEMORRHAGE 1 0.0000
300 RASH 4 0.0000
301 INCORRECT DOSE ADMINISTERED 2 0.0000
302 CHILLS 1 0.0000
303 OEDEMA PERIPHERAL 1 0.0000
304 INJECTION SITE ERYTHEMA 1 0.0000
305 DEHYDRATION 1 0.0000
306 INFECTION 1 0.0000
307 NAUSEA 5 0.0000
308 CONFUSIONAL STATE 1 0.0000
309 PNEUMONIA 2 0.0000
310 TREMOR 1 0.0000
311 TOXICITY TO VARIOUS AGENTS 1 0.0000
312 COVID-19 1 0.0000
313 CHEST PAIN 1 0.0000
314 HYPERSENSITIVITY 1 0.0000
315 DYSPNOEA 3 0.0000
316 DEATH 4 0.0000
317 WEIGHT DECREASED 1 0.0000
318 ANXIETY 1 0.0000
319 PAIN 2 0.0000
320 DIARRHOEA 2 0.0000
321 PRURITUS 1 0.0000
322 MALAISE 1 0.0000
323 VOMITING 1 0.0000